Related Experiment Video
Updated: Apr 4, 2026

05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
5.3K
Orbital Radiation Therapy in Thyroid Eye Disease
Rao V Chundury1, Adam C Weber, Julian D Perry
1Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A.
Ophthalmic Plastic and Reconstructive Surgery
|September 2, 2015
Summary
Orbital radiation therapy (ORT) is a common treatment for thyroid eye disease, an autoimmune disorder. While generally safe and well-tolerated, its exact role and effectiveness in improving vision and quality of life remain debated among experts.
Area of Science:
- Ophthalmology
- Endocrinology
- Radiation Oncology
Background:
- Thyroid eye disease (TED) is an autoimmune condition affecting orbital tissues, potentially causing vision loss.
- Moderate to severe TED necessitates treatment, with various modalities available.
- Orbital radiation therapy (ORT) is frequently employed to manage TED, potentially interrupting inflammatory processes.
Purpose of the Study:
- To systematically review the existing literature on the application and efficacy of orbital radiation therapy (ORT) in managing thyroid eye disease (TED).
Main Methods:
- A comprehensive systematic review and analysis of relevant scientific literature.
- Searches were conducted across major databases including MEDLINE/PubMed, Cochrane Library, and SCOPUS.
- Inclusion of recent peer-reviewed journal articles to ensure up-to-date information.
Main Results:
- Extensive data exists on ORT for TED, influencing treatment guidelines, yet expert consensus on its precise role is lacking.
- ORT is generally considered safe and well-tolerated in the management of TED.
- Evidence suggests ORT may offer modest early improvements in motility and proptosis and is supported for preventing compressive optic neuropathy.
Conclusions:
- Interpreting studies on ORT effectiveness is challenging due to varied TED classification systems and concurrent therapies.
- The current literature supports ORT as a safe treatment option for TED.
- Further research is needed to clarify ORT's impact on quality of life and its optimal role in TED management.
Related Concept Videos
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K

